Trade Sino Biopharmaceutical Limited - 1177 CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.06
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investmentHK$1,000.00Overnight funding adjustmentCharges from full value of position-0.018119 %(-HK$3.62)Trade size with leverage ~ HK$20,000.00Money from leverage ~ HK$19,000.00Go to platform: -0.01812%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investmentHK$1,000.00Overnight funding adjustmentCharges from full value of position-0.003799 %(-HK$0.76)Trade size with leverage ~ HK$20,000.00Money from leverage ~ HK$19,000.00Go to platform: -0.00380%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: HKD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: Hong Kong
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: HK$1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.018119 %
  (-HK$3.62)

• Margin. Your investment: HK$1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.003799 %
  (-HK$0.76)

Key Stats

• Prev. Close: 5.08
• Open: 5.16
• 1-Year Change: -29.89%
• Day's Range: 4.98 - 5.24

Trade Sino Biopharmaceutical Limited - 1177

What is Sino Biopharmeceutical (1177)?

Sino Biopharmaceutical Limited is a Chinese pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company focuses on traditional Chinese medicine and chemical pharmaceuticals, offering a range of products that address various therapeutic areas including cardiovascular, respiratory, and digestive diseases. It operates through several subsidiaries and maintains a significant presence in the healthcare sector within China. Sino Biopharmaceutical also invests in biotechnology research and development to enhance its product portfolio. The company collaborates with academic institutions and research organizations to advance pharmaceutical innovation. Its operations encompass both the production of active pharmaceutical ingredients and finished dosage forms. Sino Biopharmaceutical's business model integrates research, manufacturing, and sales, aiming to contribute to the healthcare industry by providing effective medical solutions. The company is part of a broader ecosystem of pharmaceutical enterprises in China, contributing to the development and accessibility of medicines domestically and potentially in international markets.

Sino Biopharmeceutical Stock Price Today: Live Overview

The price today is shaped by active trading in Sino Biopharmeceutical, currently valued at HK$5.1. It has fluctuated between HK$4.98 and HK$5.28 during the session, reflecting a daily change of -0.7874%.

FAQ: Sino Biopharmeceutical (1177)

What is the current price of 1177 stock?

The current price stands at HK$5.1.

Does 1177 pay dividends?

Dividends are paid by the company via cash distributions (if applicable).

Does 1177 have a formal corporate presence or regional headquarters in the UAE?

The company operates in the UAE through partners and distributors, without an official regional office or subsidiary.

What is 1177 best known for?

The company is most famous for its pharmaceutical products and biopharmaceutical innovations.

What assets are typically shown together with 1177?

Commonly shown alongside 1177: Chatham Lodging Trust, Shake Shack, Inc., Bank Of China